Issues related to reimbursement under Medicare Part B Issues related to Medicare Part D, generally Issues related to the 340B Drug Pricing Program
2025 · 1st Quarter (Jan 1 - Mar 31)
BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO)
Filed by ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC).
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 20, 2025
- Income
- $60,000.00
- Expenses
- Not reported
- Registrant
- ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC)
- Filing UUID
- 3ff1548c-821c-4d4b-a5c2-ab35596f9fd1
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to drug pricing and value, generally Issues related to pharmacy benefit managers and drug rebate reform Issues related to drug patents and patent reporting requirements H.R. 946, the ORPHAN Cures Act H.R. 1262/S. 932, the Give Kids a Chance Act
Literal federal measure citations: H.R. 946, H.R. 1262, S. 932
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.